The greater in vivo antiplatelet effects of prasugrel compared to clopidogrel reflect more efficient generation of its active metabolite with similar antiplatelet activity to clopidogrel‘s active metabolite - Sugidachi, A; Ogawa, T; Kurihara, A (J Thromb Haemost, 2007)
et al.